-
Chapter
Compassionate Care and Health Economics
Where a measure of compassionate care exists at all, they fail to produce any summary measure of utility to be compared across alternatives in an economic evaluation. The example of the preference-based measur...
-
Article
Open AccessThe relationship between headache-attributed disability and lost productivity: 2. Empirical evidence from population-based studies in nine disparate countries
Headache disorders are disabling, with major consequences for productivity, yet the literature is silent on the relationship between headache-attributed disability and lost productivity, often erroneously rega...
-
Article
Open AccessStructured headache services as the solution to the ill-health burden of headache. 2. Modelling effectiveness and cost-effectiveness of implementation in Europe: methodology
Health economic evaluations support health-care decision-making by providing information on the costs and consequences of health interventions. No universally accepted methodology exists for modelling effectiv...
-
Article
Open AccessStructured headache services as the solution to the ill-health burden of headache. 3. Modelling effectiveness and cost-effectiveness of implementation in Europe: findings and conclusions
There have been several calls for estimations of costs and consequences of headache interventions to inform European public-health policies. In a previous paper, in the absence of universally accepted methodol...
-
Article
Open AccessStructured headache services as the solution to the ill-health burden of headache: 1. Rationale and description
In countries where headache services exist at all, their focus is usually on specialist (tertiary) care. This is clinically and economically inappropriate: most headache disorders can effectively and more effi...
-
Chapter
The Healthcare Solution to Headache
This chapter builds on Chap. 14, describing structured headache services as the healthcare solution to headache.
-
Article
Open AccessA cluster randomised control trial to evaluate the effectiveness and cost-effectiveness of the Italian medicines use review (I-MUR) for asthma patients
The economic burden of asthma, which relates to the degree of control, is €5 billion annually in Italy. Pharmacists could help improve asthma control, reducing this burden. This study aimed to evaluate the eff...
-
Article
Open AccessWhat, who and when? Incorporating a discrete choice experiment into an economic evaluation
Economic evaluation focuses on Quality-Adjusted-Life-Years (QALYs) as the main valuation method. However, it is well known that factors beyond health related quality of life are important to patients and the p...
-
Article
The Authors’ Reply to Koeser and McCrone: “On the Use and Interpretation of Quantile Regression in Quality-of-Life Research”
-
Article
Valuing Benefits to Inform a Clinical Trial in Pharmacy
The generic health-related quality-of-life (HR-QOL) utility measures the EQ-5D and SF-6D are both commonly used to inform healthcare policy developments. However, their application to pharmacy practice is limi...
-
Article
Open AccessWhat determines patient preferences for treating low risk basal cell carcinoma when comparing surgery vs imiquimod? A discrete choice experiment survey from the SINS trial
The SINS trial (Controlled Clinical Trials ISRCTN48755084; Eudract No. 2004-004506-24) is a randomised controlled trial evaluating long term success of excisional surgery vs. imiquimod 5% cream for low risk no...
